Hans Hasselbalch | The Novo Nordisk Foundation Prize
Skip to content

2021

Hans Hasselbalch

2021 Hagedorn Prize awarded to pioneer in blood cancer research

Hans Hasselbalch

Unwittingly, 10,000 people in Denmark have chronic blood cancer and risk developing life-threatening blood clots. Professor Hans Hasselbalch has dedicated his career to research in this field, which he describes as being near to his heart. He is receiving the 2021 Hagedorn Prize accompanied by DKK 1.5 million for his impressive and pioneering efforts.

image

Download image